{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:25:28Z","timestamp":1789719928007,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41386-021-01246-5","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T18:02:39Z","timestamp":1639159359000},"page":"1114-1120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Benzodiazepine use and neuroimaging markers of Alzheimer\u2019s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort"],"prefix":"10.1038","volume":"47","author":[{"given":"Quentin","family":"Gallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bouteloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Odile","family":"Habert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Delrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Lebouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Bulteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Chlo\u00e9","family":"Balageas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-4634","authenticated-orcid":false,"given":"Alexandre","family":"Surget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-5974","authenticated-orcid":false,"given":"Catherine","family":"Belzung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7087-2312","authenticated-orcid":false,"given":"Nicolas","family":"Arlicot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Joao","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Barantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Cottier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Gissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wissam","family":"El-Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-221X","authenticated-orcid":false,"given":"Vincent","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-8389","authenticated-orcid":false,"given":"Thomas","family":"Desmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MEMENTO study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"1246_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","volume":"47","author":"MM Islam","year":"2016","unstructured":"Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen PA, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology. 2016;47:181\u201391.","journal-title":"Neuroepidemiology"},{"key":"1246_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","volume":"17","author":"L-Y Tseng","year":"2020","unstructured":"Tseng L-Y, Huang S-T, Peng L-N, Chen L-K, Hsiao F-Y. Benzodiazepines, z-hypnotics, and risk of dementia: special considerations of half-lives and concomitant use. Neurotherapeutics. 2020;17:156\u201364.","journal-title":"Neurotherapeutics"},{"key":"1246_CR3","doi-asserted-by":"crossref","unstructured":"Osler M, J\u00f8rgensen MB. Associations of benzodiazepines, Z-drugs, and other anxiolytics with subsequent dementia in patients with affective disorders: a nationwide cohort and nested case-control study. Am J Psychiatry. 2020;177:497\u2013505.","DOI":"10.1176\/appi.ajp.2019.19030315"},{"key":"1246_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.31372\/20180304.1016","volume":"3","author":"AT Reyes","year":"2018","unstructured":"Reyes AT, Constantino RE, Arenas RA, Bombard JN, Acupan AR. Exploring challenges in conducting E-mental health research among Asian American women. AsianPacific Isl Nurs J. 2018;3:139\u201353.","journal-title":"AsianPacific Isl Nurs J"},{"key":"1246_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12640-014-9478-8","volume":"26","author":"C Quiroga","year":"2014","unstructured":"Quiroga C, Chaparro RE, Karlnoski R, Erasso D, Gordon M, Morgan D, et al. Effects of repetitive exposure to anesthetics and analgesics in the Tg2576 mouse Alzheimer\u2019s model. Neurotox Res. 2014;26:414\u201321.","journal-title":"Neurotox Res."},{"key":"1246_CR6","doi-asserted-by":"publisher","first-page":"14299","DOI":"10.1523\/JNEUROSCI.3383-10.2010","volume":"30","author":"D Tampellini","year":"2010","unstructured":"Tampellini D, Capetillo-Zarate E, Dumont M, Huang Z, Yu F, Lin MT, et al. Effects of synaptic modulation on -amyloid, synaptophysin, and memory performance in Alzheimer\u2019s disease transgenic mice. J Neurosci. 2010;30:14299\u2013304.","journal-title":"J Neurosci."},{"key":"1246_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbrc.2015.01.022","volume":"457","author":"N Yamamoto","year":"2015","unstructured":"Yamamoto N, Arima H, Sugiura T, Hirate H, Kusama N, Suzuki K, et al. Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor. Biochem Biophys Res Commun. 2015;457:547\u201353.","journal-title":"Biochem Biophys Res Commun."},{"key":"1246_CR8","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jagp.2016.04.013","volume":"24","author":"JK Chung","year":"2016","unstructured":"Chung JK, Nakajima S, Shinagawa S, Plitman E, Chakravarty MM, Iwata Y, et al. Benzodiazepine use attenuates cortical \u03b2-Amyloid and is not associated with progressive cognitive decline in nondemented elderly adults: a pilot study using F18-Florbetapir positron emission tomography. Am J Geriatr Psychiatry. 2016;24:1028\u201339.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1246_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","volume":"84","author":"T Desmidt","year":"2019","unstructured":"Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas AC, et al. Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort. Neurobiol. Aging. 2019;84:61\u201369.","journal-title":"Neurobiol. Aging"},{"key":"1246_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13195-017-0288-0","volume":"9","author":"C Dufouil","year":"2017","unstructured":"Dufouil C, Dubois B, Vellas B, Pasquier F, Blanc F, Hugon J, et al. Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Alzheimers Res Ther. 2017;9:67.","journal-title":"Alzheimers Res Ther."},{"key":"1246_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.2967\/jnumed.109.069088","volume":"51","author":"DF Wong","year":"2010","unstructured":"Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, et al. In vivo imaging of amyloid deposition in alzheimer disease using the radioligand 18 F-AV-45 (Flobetapir F 18). J Nucl Med. 2010;51:913\u201320.","journal-title":"J Nucl Med."},{"key":"1246_CR12","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol. 2012;11:669\u201378.","journal-title":"Lancet Neurol"},{"key":"1246_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12021-016-9295-8","volume":"14","author":"G Operto","year":"2016","unstructured":"Operto G, Chupin M, Batrancourt B, Habert MO, Colliot O, Benali H, et al. CATI: a large distributed infrastructure for the neuroimaging of cohorts. Neuroinformatics. 2016;14:253\u201364.","journal-title":"Neuroinformatics"},{"key":"1246_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-016-0141-8","volume":"3","author":"M-O Habert","year":"2016","unstructured":"Habert M-O, Marie S, Bertin H, Reynal M, Martini JB, Diallo M, et al. Optimization of brain PET imaging for a multicentre trial: the French CATI experience. EJNMMI Phys. 2016;3:6.","journal-title":"EJNMMI Phys"},{"key":"1246_CR15","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","volume":"26","author":"J Ashburner","year":"2005","unstructured":"Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839\u201351.","journal-title":"Neuroimage"},{"key":"1246_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.neuroimage.2009.02.013","volume":"46","author":"M Chupin","year":"2009","unstructured":"Chupin M, Hammers A, Liu RSN, Colliot O, Burdett J, Bardinet E, et al. Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. Neuroimage. 2009;46:749\u201361.","journal-title":"Neuroimage"},{"key":"1246_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12149-017-1221-0","volume":"32","author":"M-O Habert","year":"2018","unstructured":"Habert M-O, Bertin H, Labit M, Diallo M, Marie S, Martineau K, et al. Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds. Ann Nucl Med. 2018;32:75\u201386.","journal-title":"Ann Nucl Med."},{"key":"1246_CR18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1532-5415.2008.02040.x","volume":"57","author":"SI Haider","year":"2009","unstructured":"Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people: polypharmacy and inappropriate drug use in the elderly. J Am Geriatr Soc. 2009;57:62\u201369.","journal-title":"J Am Geriatr Soc"},{"key":"1246_CR19","doi-asserted-by":"publisher","unstructured":"Crowe SF, Stranks E. Sci-Hub | The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis. Arch Clin Neuropsychol. 2017. https:\/\/doi.org\/10.1093\/arclin\/acx120. https:\/\/sci-hubtw.hkvisa.net\/.","DOI":"10.1093\/arclin\/acx120"},{"key":"1246_CR20","doi-asserted-by":"publisher","first-page":"20m13410","DOI":"10.4088\/JCP.20m13410","volume":"82","author":"I Conejero","year":"2021","unstructured":"Conejero I, Dubois J, Gutierrez LA, Delrieu J, Arbus C, Garcia M, et al. Amyloid burden and depressive symptom trajectories in older adults at risk of developing cognitive decline. J Clin Psychiatry. 2021;82:20m13410.","journal-title":"J Clin Psychiatry"},{"key":"1246_CR21","doi-asserted-by":"publisher","first-page":"146546","DOI":"10.1016\/j.brainres.2019.146546","volume":"1727","author":"F Chen","year":"2020","unstructured":"Chen F, Bertelsen AB, Holm IE, Nyengaard JR, Rosenberg R, Dorph-Petersen KA. Hippocampal volume and cell number in depression, schizophrenia, and suicide subjects. Brain Res. 2020;1727:146546.","journal-title":"Brain Res"},{"key":"1246_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s11065-014-9263-8","volume":"24","author":"M Fouquet","year":"2014","unstructured":"Fouquet M, Besson FL, Gonneaud J, La Joie R, Ch\u00e9telat G. Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan. Neuropsychol Rev. 2014;24:290\u20139.","journal-title":"Neuropsychol Rev."},{"key":"1246_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.410430307","volume":"43","author":"CR Jack","year":"1998","unstructured":"Jack CR, Petersen RC, Xu YC, O'Brien PC, Waring SC, Tangalos EG, et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer\u2019s disease. Ann Neurol. 1998;43:303\u201310.","journal-title":"Ann Neurol."},{"key":"1246_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12021-016-9295-8","volume":"14","author":"G Operto","year":"2016","unstructured":"Operto G, Chupin M, Batrancourt B, Habert MO, Colliot O, Benali H, et al. CATI: a large distributed infrastructure for the neuroimaging of cohorts. Neuroinformatics. 2016;14:253\u201364.","journal-title":"Neuroinformatics"},{"key":"1246_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuropharm.2018.11.003","volume":"144","author":"V Pilipenko","year":"2019","unstructured":"Pilipenko V, Narbute K, Pupure J, Rumaks J, Jansone B, Klusa V. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer\u2019s disease model rats. Neuropharmacology. 2019;144:319\u201326.","journal-title":"Neuropharmacology"},{"key":"1246_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.brainres.2015.12.018","volume":"1632","author":"BD Arbo","year":"2016","unstructured":"Arbo BD, Marques CV, Ruiz-Palmero I, Ortiz-Rodriguez A, Ghorbanpoor S, Arevalo MA, et al. 4\u2032-Chlorodiazepam is neuroprotective against amyloid-beta through the modulation of survivin and bax protein expression in vitro. Brain Res. 2016;1632:91\u201397.","journal-title":"Brain Res"},{"key":"1246_CR27","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s13311-017-0541-z","volume":"14","author":"RP Haberman","year":"2017","unstructured":"Haberman RP, Branch A, Gallagher M. Targeting neural hyperactivity as a treatment to stem progression of late-onset Alzheimer\u2019s disease. Neurotherapeutics. 2017;14:662\u201376.","journal-title":"Neurotherapeutics"},{"key":"1246_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nn.2801","volume":"14","author":"AW Bero","year":"2011","unstructured":"Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, et al. Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition. Nat Neurosci. 2011;14:750\u20136.","journal-title":"Nat Neurosci."},{"key":"1246_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","volume":"58","author":"JR Cirrito","year":"2008","unstructured":"Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, et al. Endocytosis is required for synaptic activity-dependent release of amyloid-\u03b2 in vivo. Neuron. 2008;58:42\u201351.","journal-title":"Neuron"},{"key":"1246_CR30","doi-asserted-by":"publisher","first-page":"20150429","DOI":"10.1098\/rstb.2015.0429","volume":"371","author":"MA Busche","year":"2016","unstructured":"Busche MA, Konnerth A. Impairments of neural circuit function in Alzheimer\u2019s disease. Philos Trans R Soc B Biol Sci. 2016;371:20150429.","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"1246_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-\u03b2 levels in vivo. Neuron. 2005;48:913\u201322.","journal-title":"Neuron"},{"key":"1246_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1523\/JNEUROSCI.2531-15.2016","volume":"36","author":"P Yuan","year":"2016","unstructured":"Yuan P, Grutzendler J. Attenuation of -amyloid deposition and neurotoxicity by chemogenetic modulation of neural activity. J Neurosci. 2016;36:632\u201341.","journal-title":"J Neurosci."},{"key":"1246_CR33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.2174\/138161207781368710","volume":"13","author":"L Veenman","year":"2007","unstructured":"Veenman L, Papadopoulos V, Gavish M. Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr Pharm Des. 2007;13:2385\u2013405.","journal-title":"Curr Pharm Des."},{"key":"1246_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jsbmb.2015.07.007","volume":"154","author":"BD Arbo","year":"2015","unstructured":"Arbo BD, Benetti F, Garcia-Segura LM, Ribeiro MF. Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases. J. Steroid Biochem Mol Biol. 2015;154:68\u201374.","journal-title":"J. Steroid Biochem Mol Biol."},{"key":"1246_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pscychresns.2018.08.015","volume":"281","author":"S Huhtaniska","year":"2018","unstructured":"Huhtaniska S, Korkala I, Heikka T, Bj\u00f6rnholm L, Lehtiniemi H, Hulkko AP, et al. Antipsychotic and benzodiazepine use and brain morphology in schizophrenia and affective psychoses \u2013 Systematic reviews and birth cohort study. Psychiatry Res Neuroimaging. 2018;281:43\u201352.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"1246_CR36","doi-asserted-by":"publisher","first-page":"e84806","DOI":"10.1371\/journal.pone.0084806","volume":"8","author":"SC Licata","year":"2013","unstructured":"Licata SC, Shinday NM, Huizenga MN, Darnell SB, Sangrey GR, Rudolph U, et al. Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS ONE. 2013;8:e84806.","journal-title":"PLoS ONE"},{"key":"1246_CR37","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1212\/WNL.0000000000000386","volume":"82","author":"CR Jack Jr","year":"2014","unstructured":"Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, et al. Rates of -amyloid accumulation are independent of hippocampal neurodegeneration. Neurology. 2014;82:1605\u201312.","journal-title":"Neurology"},{"key":"1246_CR38","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0306-4522(97)00146-2","volume":"80","author":"G Sperk","year":"1997","unstructured":"Sperk G, Schwarzer C, Tsunashima K, Fuchs K, Sieghart W. GABAA receptor subunits in the rat hippocampus I: Immunocytochemical distribution of 13 subunits. Neuroscience. 1997;80:987\u20131000.","journal-title":"Neuroscience"},{"key":"1246_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neuroscience.2015.04.053","volume":"309","author":"JC Kreutzmann","year":"2015","unstructured":"Kreutzmann JC, Havekes R, Abel T, Meerlo P. Sleep deprivation and hippocampal vulnerability: changes in neuronal plasticity, neurogenesis and cognitive function. Neuroscience. 2015;309:173\u201390.","journal-title":"Neuroscience"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01246-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01246-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T08:09:17Z","timestamp":1647850157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-021-01246-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1246"],"URL":"https:\/\/doi.org\/10.1038\/s41386-021-01246-5","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"2 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TD reports personal fees from Lundbeck, Otsuka and Eisai. GR reports personal fees from Janssen & Janssen and Ostuka. RD reports personal fees from Janssen & Janssen, lundbeck, Lilly, BMS, Servier, Eisai and Biogen. WE reports personal fees from Eisai, Janssen, Lundbeck, Otsuka, UCB, Roche and Chugai. VC reports personal fees from Janssen and Bristol Meyers Squibb. All other authors declare no competing interests. As far as we are aware of, among the pharmaceutical companies mentioned here, only Roche is involved in the production of benzodiazepines (namely diazepam, in its marketed form of Valium in France). Neither Roche nor any of the other pharmaceutical companies mentioned here were consulted regarding the planning or analysis of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}